Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors is a research paper published in The Journal of Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: 5R35CA19735305
HHS | National Institutes of Health
Grant: CA227942
NCI NIH HHS
Grant: R01 CA227942
NCI NIH HHS
Grant: R35 CA197353
National Institutes of Health
Grant: 5R01CA227942-19
Targeting the Cancer Glycocalyx
Howard Hughes Medical Institute
St Baldrick's/Stand Up 2 Cancer Pediatric Dream Team Translational Cancer Research Grant
National Science Foundation
American Cancer Society
American Society of Hematology
FWCI
0.37
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals